+44-330-822-4832
+44-330-822-4832Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
HER2-Targeted Antibody Treatment for Ovarian Cancer Future Opportunities
There are an estimated 240,000 new cases of ovarian cancer diagnosed worldwide each year. Due to late presentation, in many parts of the world it remains the most lethal gynecological cancer. In 2004, a new model description of this disease was proposed that combined both histopathological and molecular features and which classified epithelial ovar... Read More»
Simon P Langdon and Andrew H Sims
Editorial: J Mol Pharm Org Process Res 2016, 4:1
DOI: 10.4172/2329-9053.1000e125
Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 
